GRAS Notices
-
GRN No. 950
Bifidobacterium longum subsp. infantis DSM 33361
| Intended Use: | For use as an ingredient in cow milk-, soy-, and partially hydrolyzed protein-based, non-exempt infant formula for term infants at a level up to 1 x 1010 colony forming units (CFU)/g, and in conventional foods, including but not limited to milk and dairy products; plant-based dairy alternatives; beverages; bars; confectionery; and cereals and at a use level up to 2.8 x 1010 CFU/serving. |
|---|---|
| Basis: | Scientific procedures |
| Notifier: | Chr. Hansen, Inc. |
| Notifier Address: |
9015 West Maple Street Milwaukee, WI 53214 |
| GRAS Notice (releasable information): | GRN 950 Part 1 (in PDF) (11.5 MB) |
| Part 2: | GRN 950 Part 2 (in PDF) (8.9 MB) |
| Part 3: | GRN 950 amendments (8.3 MB) |
| Date of closure: | Mar 1, 2021 |
| FDA's Letter: | FDA has no questions (in PDF) (281 kB) |
-
